Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Long-term hemodialysis patients may have many comorbidities, among which hyperphosphorus is the most common, more than 50% of dialysis patients have this problem, hyperphosphorus can easily lead to secondary hyperparathyroidism, renal bone lesions and cardiovascular calcification, etc., further increasing the incidence of coronary artery disease and myocardial infarction, thereby increasing the risk of death; According to multiple research literatures, the average adherence rate of oral phosphorus binders in hemodialysis patients does not exceed 50%, and the research on this issue in Taiwan is relatively limited. As the medical environment and patient behavior change, it is worth further exploration to provide more effective intervention strategies.
This study adopts a cross-sectional correlation study design, using the hemodialysis room of a regional teaching hospital as the research site, and the subjects are aged ≧ 18 years old, who have been receiving hemodialysis treatment for ≧ 3 months, take oral phosphorus binders and are conscious, and can complete the questionnaire on their own or verbally. The research tool was based on the "Oral Phosphorus Conjugate Adherence Behavior Scale" compiled by He Yafang et al. (2015), which was reviewed by experts for validity, and its content validity index (CVI) was 0.87, and Conbach's ɑ was 0.87.
The majority of the subjects were 93 men (63%), aged 35-86 years, with an average age of 66.44 years (SD=10.13), and the number of dialysis months ranged from 3-233 months, with an average of 62.91 months. There was a significant correlation between gender (t=-2.168, p=0.032), and women had better compliance. There was a mild positive correlation between age (r=0.252, p= 0.002), and the older people had better adherence to phosphorus binders. Education attainment was significantly correlated (t=2.196, p=0.030), with high school (vocational) and below being better, and only 12% of those fully compliant with oral phosphorus binders.
This study showed that subjects had lower medication adherence in certain situations. For example, in the "Don't forget to take calcium tablets while eating snacks", the average score was 3.13 out of 5, SD = 1.26, indicating that the implementation of medication during non-meal periods is less accurate. It is recommended that clinical medical teams consider individual dietary patterns when using oral phosphorus binders to treat patients with hyperphosphorus, rather than just taking three meals with meals, and improve patients' adherence and efficacy to medication through more flexible and individualized health education strategies.
